XOMAP Q1 2020 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$804,000-90.1% YoY

Gross Profit

$742,00092.3% margin

Operating Income

-$6M-698.5% margin

Net Income

-$5M-591.8% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+90.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$92M

Total Liabilities

$51M

Stockholders' Equity

$41M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$804,000	$8M	-90.1%
Gross Profit	$742,000	$8M	-90.6%
Operating Income	-$6M	$2M	-390.1%
Net Income	-$5M	$3M	-247.2%